ELANE:an emerging lane to selective anticancer therapy  

作　　者：Boqiang Peng Jiankun Hu Xianghui Fu 

机构地区：[1]Laboratory of Gastric Cancer and Department of Gastrointestinal Surgery,State Key Laboratory of Biotherapy and Cancer Center,West China Hospital,Sichuan University and Collaborative Innovation Center of Biotherapy,Chengdu,Sichuan,China [2]Division of Endocrinology and Metabolism,State Key Laboratory of Biotherapy and Cancer Center,West China Hospital,Sichuan University and Collaborative Innovation Center of Biotherapy,Chengdu,Sichuan,China

出　　处：《Signal Transduction and Targeted Therapy》2021年第11期3155-3156,共2页信号转导与靶向治疗（英文）

基　　金：This work was supported by the National Natural Science Foundation of China(81970561);the Ministry of Science and Technology of China(2018ZX09201018-005);the 1.3.5 Project for Disciplines of Excellence,West China Hospital,Sichuan University(ZYJC18049).

摘　　要：Recently,Cui et al.1 revealed that neutrophil elastase(ELANE)can selectively kill a wide range of cancer cells while sparing proximal non-cancer cells and significantly attenuate tumorigenesis,suggesting a promising selective and broad anticancer strategy.

关 键 词：CANCER PROXIMAL 

分 类 号：R730.5[医药卫生—肿瘤]